ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
25 announcements with these filters
Stallion India Fluorochemicals schedules a 13 November 2026 board meeting for unaudited September quarter results. Trading window stays closed until 15 November 2026.
Stallion India Fluorochemicals cancelled its analyst/investor meeting scheduled for 6 November 2026. The virtual meeting carried no financial or business event.
Stallion India Fluorochemicals reported the completion of a Maharashtra GST inspection. The company has paid the resulting tax and interest liabilities with no material operational impact.
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, as mandated by SEBI regulations.
Swati Ghosh has been regularised as a Non-Executive Independent Director at Stallion India Fluorochemicals Limited. This designation change was effective from September 21, 2026.
Stallion India Fluorochemicals held its 24th AGM on September 21, 2026, to discuss financial statement adoption and director appointments. Official results will be disclosed separately.
Stallion India Fluorochemicals has commenced commercial operations at its new Semiconductor & Specialty Gas debulking and blending facility in Khalapur, Maharashtra. The plant has an aggregate annual capacity of 1,200 MT.
Stallion India Fluorochemicals Ltd has filed its Annual Report for FY 2025-26 and notified the cut-off date for its 24th Annual General Meeting.
Stallion India Fluorochemicals Limited has issued a notice for its 24th Annual General Meeting, scheduled to be held on September 21, 2026.
Stallion India Fluorochemicals delivered strong Q1 FY27 results with Revenue at ₹124.68 cr (up 12.78% YoY). Strategy focuses on backward integration through new R32 and HFO plants to boost margins.
Stallion India reports strong Q1 FY27 results with 79% PAT growth. Strategy shifts toward high-margin specialty gases and backward integration through a new 10,000 MT R-32 plant.
Stallion India Fluorochemicals reported Q1 FY27 results, with revenue growing 12.78% to ₹124.68 Crore and PAT surging 79.15% to ₹18.57 Crore.
Stallion India Fluorochemicals filed its Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of IPO proceeds.
Stallion India Fluorochemicals Ltd reported revenue from operations of ₹121.4 Cr (+9.9% YoY) and net profit of ₹18.6 Cr (+78.8% YoY) for Q1 FY27.
Stallion India Fluorochemicals Limited will hold a board meeting on 12-Aug-2026 to consider and approve its unaudited financial results for the quarter ended June 2026.
Stallion India Fluorochemicals Ltd submitted its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with Regulation 31(1)(b) of SEBI LODR.
Neomile Corporate Advisory and associated funds sold a 2.53% stake in Stallion India Fluorochemicals via the open market. Their remaining aggregate holding stands at 9.86%.
Stallion India Fluorochemicals Limited shareholders approved a special resolution for variation in IPO proceeds objects. The resolution passed with a 99.99% majority via postal ballot.
Stallion India reports strong FY26 performance with revenue of ₹434.12 Cr and PAT growth of 35.61%. Strategy focuses on backward integration into R-32 manufacturing and expansion into specialty/semiconductor gases.
Stallion India Fluorochemicals filed its quarterly monitoring report for its ₹160.73 Crore IPO. The company reported material deviations in issue expenses and working capital utilization.
Stallion India Fluorochemicals submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory adherence with no adverse observations.
Stallion India Fluorochemicals reported FY26 revenue growth of 14.40% to ₹434.12 Crore. PAT increased 35.61%, driven by strategic preparedness and operational resilience.
Stallion India Fluorochemicals appointed Ms. Swati Ghosh as an Independent Director for five years. Her secretarial expertise will strengthen board compliance and regulatory oversight.
Stallion India Fluorochemicals Ltd reported revenue from operations of ₹110 Cr (-27.4% YoY) and net profit of ₹10.9 Cr (-18.0% YoY) for Q4 FY26.
Stallion India reported a net profit of ₹43.74 Crore for FY2026. The board also appointed Ms. Swati Ghosh as an Independent Director for five years.